Continuous Bioprocessing Market Companies
- Eppendorf AG
- 3M Company
- Thermo Fisher Scientific, Inc.
- Merck KGOA
- Meissner Corporation
- Danaher Corporation
- Bionet
- Sartorius AG
- Corning Incorporated
- Entegris, Inc.
- Repligen Corporation
- Getinge AB
- Fujifilm Holdings Corporation
Recent News:
- In May 2023, 3M Company, a pioneer in biopharma filtration technology, stated that it would invest $146 million to enhance its capabilities and assist biotech production. Biotech production is a rapidly expanding field in healthcare that is providing patients with innovative medications. Improvements to the buildings and equipment, as well as the creation of 60 full-time jobs at 3M production plants around Europe, are all part of the initiative.
- In April 2022, Thermo Fisher Scientific celebrated the grand inauguration of its new Ogden, Utah, production facility for single-use technologies. The innovative facility adds the capacity to generate the superior technologies and materials required to create novel vaccinations and ground-breaking treatments. The $44 million facility is a part of Thermo Fisher's multi-year, $650 million investment that was announced last year. The investment aims to help guarantee that there is flexible, scalable, and reliable bioprocessing production capacity for essential materials used in the development of COVID-19 and other new and existing biologics and vaccines.